Interventions for valvular disease First use of 3D-TEE model-based fully automatic fusion of 3D-MSCT and fluoroscopy during transcatheter aortic valve implantation Brouwer J, Gheorghe L, Rensing B, Swaans M November 15, 2019 | 10.4244/EIJ-D-19-00261
Coronary interventions Bioresorbable vascular scaffolds in coronary chronic total occlusions: clinical, vasomotor and optical coherence tomography findings at three-year follow-up (ABSORB-CTO study) Gheorghe L, Millan X, Jimenez-Kockar M, Gomez-Lara J, Arzamendi D, Danduch L, Agudelo V, Serra A May 20, 2019 | 10.4244/EIJ-D-18-00567
Interventions for valvular disease First use of 3D-TEE Model based Fully Automatic Fusion of 3D-MSCT and Fluoroscopy during Transcatheter Aortic Valve Implantation Brouwer J, Gheorghe L, Rensing B, Swaans M May 7, 2019 | 10.4244/EIJ-D-19-00261
Peripheral interventions How should I treat an asymptomatic aortic coarctation with a concomitant dissection of the descending aorta? Gheorghe L, Arzamendi D, Li C, Barros-Membrilla A, Munoz J, Penaranda A, Sultan S, Spence M, Collins A March 20, 2017 | 10.4244/EIJ-D-16-00169
New issue Antiplatelet strategies for complex PCI, are all DES equal at 10-year follow-up? cost-effectiveness of TAVR…find all the answers in the new issue (Intravascular lithotripsy (3.5 mm Shockwave; left), followed by balloon dilatation (4.0 mm NC; right)) December 6, 2019
Trials Book New update! Discover 17 new trials (The Trials book is supported by Biotronik) October 29, 2019
Editorial 2019 – A leap year for valvular heart disease (Course directors PCR London Valves 2019) November 15, 2019